Replies to post #185 on Micromet, Inc (f/k/a MITI)

[bradfrogger]

I wonder if the share price will go much beyond the $11/share?

[DocLee]

Is $11 Reasonable? Not to Me It Isn't!

I'm into Micromet long term since I firmly believe that just one of its products, Blinatumomab, is going to be a blockbuster and that its BiTE technology can be developed big-time. On that basis $11 is chickenfeed.

Unfortunately, Micromet's board is endorsing the bid as stated in Section C of the Recitals in the "Agreement and Plan of Merger", downloadable here:-
Merger Document

With the marked reversal of the long slow downward drift in the SP until just a few weeks ago, it is clear that someone knew that an agreed bid was being put together and decided to capitalise on it. Insider shenanigans, anybody?